Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Mouton, when I read the amicus brief before it certainly was not too "friendly" to the Momenta case and may not continue to be so. However, since the SG brief, correct me if I am wrong a few things came to light. One was that Amphastar deliberately withheld information from the court that was relevant and was subsequently reprimanded for that and the other was an admission by Amphastar that utilization of the Momenta patent was not the only way to provide required information to the FDA. If my timeline is right, these two mitigation pieces of the case not previously available to the SG might allow for a different take by the SG this time. Maybe too optimistic. Too bad Judge Raider is not still around...Regards, bp